關鍵數據
169.350今開
175.000最高
61.43K成交量
190.08本益比TTM
68.03本益比動
--股利TTM
0.10%換手率
168.480昨收
168.050最低
10.59M成交額
虧損本益比靜
5.31市淨率
0.00%股息率 TTM
1.78%ROA
198.87052週最高
0.03量比
-25.51M淨利潤
63.92M總股本
0.9135每股盈餘TTM
1.09Beta
2.51%ROE
100.99052週最低
5.12%振幅
54.19%毛利率
11.09B總市值
5.37回報/風險
2.94%風險率

即將為您帶來更多新聞,敬請期待。 。 。
Repligen Corp評分
0.05與上次評分對比預測8.10
財務診斷7.37
技術分析3.50
公司估值9.42
機構認同度10.00
風險評估5.63
分析師評級
買入評級
205.626目標均價
+16.21%漲幅空間
Repligen Corp 最新財報電話會記錄
睿力根 (RGEN) 2026年第三季法說會:營收創新高並上調財測
Repligen 2026 年第三季財報電話會議涵蓋創紀錄的 2.09 億美元營收、12.5% 的有機成長、BioLife 的整合,以及上調的全年財測指引。
財務指標
貨幣: USD

由於公司未披露,未能獲取相關數據
貨幣: USD

由於公司未披露,未能獲取相關數據
Repligen Corp 簡介
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.
行業醫療設備與耗材
公司代碼RGEN
員工數量1778
國家United States of America
持股情況
| 持股股東 | 佔比 |
|---|
| BlackRock Institutional Trust Company, N.A. | 8.31% |
|---|
| T. Rowe Price Associates, Inc. | 8.06% |
|---|
| United Capital Financial Advisors, LLC | 4.91% |
|---|
| Roy T. Eddleman UEO | 4.85% |
|---|
| 股東類型 | 佔比 |
|---|
| Investment Advisor | 62.92% |
|---|
| Investment Advisor/Hedge Fund | 38.33% |
|---|
| Hedge Fund | 9.18% |
|---|
| Individual Investor | 5.23% |
|---|
常見問題
Repligen Corp(RGEN)的當前股價是多少?
Repligen Corp(RGEN)的當前股價是 173.49。
Repligen Corp股票的52週最高點是多少?
Repligen Corp股票的52週最高點是198.87。
Repligen Corp股票的52週最低點是多少?
Repligen Corp股票的52週最低點是100.99。
現在Repligen Corp(RGEN)的股票是買入、持有還是賣出?
根據分析師評級,Repligen Corp(RGEN)的總體評級為買入,目標價格為205.63。
Repligen Corp(RGEN)股票的每股收益(EPS TTM)是多少
Repligen Corp(RGEN)股票的每股收益(EPS TTM)是0.91。